Knygos.lt klubas Knygos.lt nariams
83,57 €
-30%
Įprastai
119,39 €
Incentives for Research, Development, and Innovation in Pharmaceuticals
Incentives for Research, Development, and Innovation in Pharmaceuticals
Knygos.lt klubas Knygos.lt nariams
83,57 €
-30%
Įprastai
119,39 €
  • Išsiųsime per 12–18 d.d.
Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situatio…
  • Leidėjas:
  • Metai: 2012
  • Puslapiai: 96
  • ISBN-10: 8493806218
  • ISBN-13: 9788493806217
  • Formatas: 17 x 24.4 x 0.6 cm, minkšti viršeliai
  • Kalba: Anglų

Incentives for Research, Development, and Innovation in Pharmaceuticals (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.

Knygos.lt klubas
Knygos.lt nariams
83,57 €
-30%
Įprastai
119,39 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 1,19 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau
  • Leidėjas:
  • Metai: 2012
  • Puslapiai: 96
  • ISBN-10: 8493806218
  • ISBN-13: 9788493806217
  • Formatas: 17 x 24.4 x 0.6 cm, minkšti viršeliai
  • Kalba: Anglų

Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)
× Akcija + knyga už 1ct